Did you mean: Alina GOrokhova
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
…, NL Lubenets, DM Grousova, AS Erokhova… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
…, AS Dzharullaeva, DM Grousova, AS Erokhova… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, NL Lubenets, DM Grousova, AS Erokhova… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
…, AY Shelkov, AG Botikov, AS Erokhova… - Emerging Microbes & …, 2022 - Taylor & Francis
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B. 1.1. 529 (Omicron) SARS-CoV-2 variant
…, MM Megeryan, AS Dzharullaeva, AS Erokhova… - medRxiv, 2021 - medrxiv.org
COVID-19 vaccination campaign has been launched around the world. More than 8 billion
vaccines doses have been administered, according to the WHO. Published studies shows …
vaccines doses have been administered, according to the WHO. Published studies shows …
[HTML][HTML] Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an …
…, AA Iliukhina, AY Shelkov, AS Erokhova… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the …
…, NL Lubenets, DM Grousova, AS Erokhova… - medRxiv, 2021 - medrxiv.org
Objectives Vaccination remains the most effective response to the COVID-19 pandemic. Most
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
NOD1/2 and the C-type lectin receptors Dectin-1 and Mincle synergistically enhance proinflammatory reactions both in vitro and in vivo
…, AS Dzharullaeva, AS Erokhova… - Journal of …, 2020 - Taylor & Francis
Purpose Pathogens consist of a wide variety of evolutionarily conserved molecular
structures that are recognized by pattern recognition receptors (PRRs) of innate immunity. …
structures that are recognized by pattern recognition receptors (PRRs) of innate immunity. …
Stimulation of Dectin‐1 and Dectin‐2 during parenteral immunization, but not Mincle, induces secretory IgA in intestinal mucosa
…, AI Tukhvatulin, AS Erokhova… - Journal of …, 2018 - Wiley Online Library
Induction of a robust and long‐lived mucosal immune response during vaccination is critical
to achieve protection against numerous pathogens. However, traditional injected vaccines …
to achieve protection against numerous pathogens. However, traditional injected vaccines …
An open, non-randomised, 1/2 phase study on the safety, tolerability, and immunogenicity of single dose'Sputnik light'vaccine for prevention of coronavirus infection in …
…, NL Lubenets, DM Grousova, AS Erokhova… - 2021 - papers.ssrn.com
Background: While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
Did you mean to search for: Alina GOrokhova
